Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer-Reference-Cited by-同舟云学术

Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer

Published:2006-10 Issue:4 Volume:98 Page:788-793
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Briganti Alberto,Chun Felix K-H.,Salonia Andrea,Gallina Andrea,Farina Elena,Da Pozzo Luigi F.,Rigatti Patrizio,Montorsi Francesco,Karakiewicz Pierre I.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2006.06318.x/fullpdf

Reference30 articles.

1. Is a Limited Lymph Node Dissection An Adequate Staging Procedure for Prostate Cancer?

2. Extended Pelvic Lymphadenectomy In Patients Undergoing Radical Prostatectomy: High Incidence Of Lymph Node Metastasis

3. LAPAROSCOPIC PELVIC LYMPH NODE DISSECTION FOR PROSTATE CANCER: COMPARISON OF THE EXTENDED AND MODIFIED TECHNIQUES

4. Cancer Control and Quality of Life Following Anatomical Radical Retropubic Prostatectomy: Results at 10 Years

5. Prognostic Significance of Lymph Nodal Metastases in Prostate Cancer

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Additional Parameters to the Briganti Nomogram for Predicting Pelvic Lymph Node Metastasis in Prostate Cancer;Archivos Españoles de Urología;2024

2. Sentinel Lymph Node Techniques in Urologic Oncology: Current Knowledge and Application;Cancers;2023-04-26

3. Morbidité du curage ganglionnaire pelvien étendu au cours de la prostatectomie totale laparoscopique robot assistée;Progrès en Urologie;2022-12

4. Recurrence rate after radical prostatectomy following primary staging of high-risk prostate cancer with ⁶⁸Ga-PSMA PET/CT;Acta Oncologica;2022-10-03

5. Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancer;Drug Resistance Updates;2022-09